Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 19/20 | 0.62 |
| ▸ | SLC5A1 | P13866 | 12/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.37 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12257574 | 0.85 | SLC5A2 (0.71) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL12336581 | 0.81 | SLC5A2 (0.59) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL2201764 | 0.77 | SLC5A2 (1.00) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL17480515 | 0.77 | SLC5A2 (0.64) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL21697631 | 0.76 | SLC5A2 (0.60) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL12336875 | 0.76 | SLC5A2 (0.74) | SLC5A2SLC5A1 | |
| SCHEMBL12257581 | 0.72 | SLC5A2 (0.57) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL16009819 | 0.72 | SLC5A2 (0.68) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL16018606 | 0.72 | SLC5A2 (0.68) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 | |
| SCHEMBL12257454 | 0.70 | SLC5A2 (0.51) | SLC5A2SLC5A1CHRM1ADRA1ASLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1845095-B1 | 1-THIO-D-GLUCITOL DERIVATIVES | TAISHO PHARMACEUTICAL CO LTD (JP) | 2011-09-07 | — | — | EP | disclosed |